Data Collective IV GP, LLC
- SEC CIK
- 0001664974
- Latest filing
- Aug 14, 2026
Holdings in Q1 2023
Holdings as of Mar 31, 2023, filed May 15, 2023. Long positions only; changes compare share counts with Q4 2022.
- Positions
- 6
- 0 vs. Q4 2022
- Portfolio value
- $93.8M
- −$1.38M (−1.4%) vs. Q4 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RXRXRecursion Pharmaceuticals, Inc. | CL A | 5,941,120 | $39.6M | 42.2% | 00.0% | Unchanged | History |
| EVLVEvolv Technologies Holdings, Inc. | COM CL A | 10,601,281 | $33.1M | 35.2% | 00.0% | Unchanged | History |
| RKLBRocket Lab Corp | COM | 2,929,350 | $11.8M | 12.6% | +2,929,350 | New | History |
| EMBKEmbark Technology, Inc. | COM NEW | 3,186,007 | $8.95M | 9.5% | −10.0% | Reduced | History |
| DFTXDefinium Therapeutics, Inc. | Stock | 100,350 | $318.1K | 0.3% | +100,350 | New | History |
| ROIVRoivant Sciences Ltd. | SHS | 3,875 | $28.6K | <0.1% | −21,965−85.0% | Reduced | History |
Sold out since Q4 2022 (2)
Positions held at the end of Q4 2022 that are gone from this filing.